tiprankstipranks
Trending News
More News >
HCA Healthcare (HCA)
NYSE:HCA
US Market

HCA Healthcare (HCA) Ratios

Compare
1,667 Followers

HCA Healthcare Ratios

HCA's free cash flow for Q1 2025 was $0.85. For the 2025 fiscal year, HCA's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.19 1.18 1.38 1.41 1.42
Quick Ratio
1.06 1.02 1.17 1.21 1.18
Cash Ratio
0.08 0.07 0.09 0.15 0.21
Solvency Ratio
0.15 0.15 0.16 0.20 0.15
Operating Cash Flow Ratio
0.71 0.75 0.86 0.93 1.06
Short-Term Operating Cash Flow Coverage
2.76 3.89 23.03 87.83 44.17
Net Current Asset Value
$ -43.98B$ -40.22B$ -38.87B$ -35.71B$ -32.27B
Leverage Ratios
Debt-to-Assets Ratio
0.78 0.74 0.76 0.72 0.69
Debt-to-Equity Ratio
-13.20 -23.60 -14.40 -38.94 57.13
Debt-to-Capital Ratio
1.08 1.04 1.07 1.03 0.98
Long-Term Debt-to-Capital Ratio
0.00 1.05 1.08 1.03 0.98
Financial Leverage Ratio
-16.99 -31.69 -18.95 -54.39 83.02
Debt Service Coverage Ratio
2.16 2.55 5.47 7.28 4.85
Interest Coverage Ratio
5.17 4.97 5.23 6.25 4.62
Debt to Market Cap
0.04 0.53 0.55 0.41 0.56
Interest Debt Per Share
194.56 160.78 143.20 117.22 101.28
Net Debt to EBITDA
3.23 3.22 2.93 2.45 3.17
Profitability Margins
Gross Profit Margin
67.91%14.82%84.44%83.86%83.76%
EBIT Margin
14.93%14.84%17.14%19.40%13.61%
EBITDA Margin
19.65%19.58%22.06%24.26%18.89%
Operating Profit Margin
15.15%14.82%15.10%16.66%14.20%
Pretax Profit Margin
12.02%11.86%14.24%16.74%10.54%
Net Profit Margin
8.07%8.07%9.37%11.84%7.28%
Continuous Operations Profit Margin
9.33%9.38%11.35%13.14%8.51%
Net Income Per EBT
67.17%68.02%65.77%70.74%69.13%
EBT Per EBIT
79.35%80.05%94.31%100.43%74.22%
Return on Assets (ROA)
9.66%9.33%10.76%13.71%7.90%
Return on Equity (ROE)
-235.88%-295.49%-203.94%-745.55%656.29%
Return on Capital Employed (ROCE)
23.48%22.10%21.39%23.79%18.86%
Return on Invested Capital (ROIC)
16.94%16.42%16.75%18.39%15.01%
Return on Tangible Assets
11.66%11.33%13.19%16.88%9.65%
Earnings Yield
6.55%7.11%8.10%8.37%6.75%
Efficiency Ratios
Receivables Turnover
6.46 6.52 6.77 7.25 7.30
Payables Turnover
5.12 13.07 2.21 2.31 2.37
Inventory Turnover
12.81 27.38 4.53 4.77 4.13
Fixed Asset Turnover
2.25 2.17 2.18 2.24 2.04
Asset Turnover
1.20 1.16 1.15 1.16 1.09
Working Capital Turnover Ratio
37.05 21.61 15.64 15.48 14.58
Cash Conversion Cycle
13.74 41.40 -30.68 -31.45 -15.86
Days of Sales Outstanding
56.54 55.99 53.88 50.36 50.00
Days of Inventory Outstanding
28.50 13.33 80.55 76.46 88.32
Days of Payables Outstanding
71.30 27.92 165.11 158.27 154.17
Operating Cycle
85.04 69.32 134.43 126.82 138.31
Cash Flow Ratios
Operating Cash Flow Per Share
38.87 34.62 29.35 27.71 27.29
Free Cash Flow Per Share
19.84 17.21 14.21 16.65 18.91
CapEx Per Share
19.03 17.42 15.14 11.06 8.38
Free Cash Flow to Operating Cash Flow
0.51 0.50 0.48 0.60 0.69
Dividend Paid and CapEx Coverage Ratio
1.78 1.74 1.69 2.13 3.09
Capital Expenditure Coverage Ratio
2.04 1.99 1.94 2.50 3.26
Operating Cash Flow Coverage Ratio
0.21 0.23 0.21 0.25 0.28
Operating Cash Flow to Sales Ratio
0.14 0.15 0.14 0.15 0.18
Free Cash Flow Yield
5.81%6.36%5.92%6.48%11.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.27 14.07 12.35 11.94 14.82
Price-to-Sales (P/S) Ratio
1.19 1.13 1.16 1.41 1.08
Price-to-Book (P/B) Ratio
-25.07 -41.56 -25.18 -89.03 97.26
Price-to-Free Cash Flow (P/FCF) Ratio
17.20 15.73 16.88 15.43 8.70
Price-to-Operating Cash Flow Ratio
9.10 7.82 8.18 9.27 6.03
Price-to-Earnings Growth (PEG) Ratio
8.23 -13.67 -1.28 0.13 1.83
Price-to-Fair Value
-25.07 -41.56 -25.18 -89.03 97.26
Enterprise Value Multiple
9.28 9.01 8.17 8.28 8.89
Enterprise Value
130.47B 114.66B 108.60B 117.95B 86.52B
EV to EBITDA
9.28 9.01 8.17 8.28 8.89
EV to Sales
1.82 1.76 1.80 2.01 1.68
EV to Free Cash Flow
26.37 24.46 26.31 21.92 13.52
EV to Operating Cash Flow
13.46 12.16 12.74 13.17 9.37
Tangible Book Value Per Share
-1.76 -32.62 -33.50 -24.90 -16.81
Shareholders’ Equity Per Share
-14.11 -6.51 -9.53 -2.89 1.69
Tax and Other Ratios
Effective Tax Rate
0.22 0.21 0.20 0.21 0.19
Revenue Per Share
286.98 238.50 207.45 181.72 152.34
Net Income Per Share
23.17 19.24 19.44 21.51 11.10
Tax Burden
0.67 0.68 0.66 0.71 0.69
Interest Burden
0.80 0.80 0.83 0.86 0.77
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.22 0.45 0.46 0.46 0.46
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.56 1.80 1.25 1.16 2.10
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis